Page 39 - Read Online

Page 270 Lyulcheva-Bennett et al. J Transl Genet Genom 2023;7:259-73 https://dx.doi.org/10.20517/jtgg.2023.33

Furthermore, the prevalence of psychological distress (e.g., anxiety, depression) is much higher in
[47]
individuals with long-term health conditions compared to the general population . Where significant
behavioural difficulties arise, specialist psychological assessment and tailored support are indicated,
highlighting the importance of integrated psychology provision within specialist MDTs [Table 2].

Emotional and psychological support
Beyond the physical and developmental challenges faced by individuals with MBS, the emotional and
psychological toll on both patients and their families cannot be overlooked [3,14,19] . Psychosocial screening,
comprehensive assessments, and tailored screenings are essential to address feelings of isolation, anxiety,
and low self-esteem that may arise due to the condition. Families, too, benefit from support groups and
counselling to better understand and cope with the challenges of raising a child with MBS.

Education and specialist MDT team
Education plays a pivotal role in the holistic management of MBS. It is essential that the affected child’s
educational setting is well-informed about the condition, its implications, and the specific needs of the child.
The specialist MDT team should liaise closely with educators to ensure that necessary accommodations are
made in the school environment. This includes tailored learning plans, physical adaptations, and ensuring
that peers and educators are sensitised to the condition, promoting an inclusive and supportive learning
environment. Such collaborative efforts between healthcare professionals and educational institutions
ensure that the child receives consistent support, both medically and academically, fostering an
environment where they can thrive and reach their full potential.

The management of Moebius syndrome is a multifaceted endeavour that requires a holistic approach [8,14]
[Table 2]. The emphasis on early diagnosis, multidisciplinary input, and access to specialist teams familiar
with this rare condition is paramount for achieving the best outcomes for patients.

CONCLUSION
Moebius syndrome embodies many challenges within the varied landscape of neurodevelopmental
disorders. This review provides an overview of the current understanding of MBS and highlights future
approaches to further elucidate disease aetiology to enhance medical understanding and improve patient
care.

Our current understanding of Moebius syndrome is that it is a consequence of multiple pathological
processes that impact a common developmental pathway. Moebius remains a clinical diagnosis for a
heterogeneous group of patients with a constellation of clinical features, where other conditions have been
excluded. Despite the challenges associated with Moebius syndrome, advances in genetic research have led
to the identification of several genes associated with the disorder, and ongoing research continues to shed
light on the complex interplay between genetic and environmental factors in the development of Moebius
syndrome. Careful genomic analysis, combined with deep phenotyping and standardised reporting of
clinical diagnoses, will facilitate future research towards a better understanding of this enigmatic
neurodevelopmental syndrome.

However, many questions remain. For example, why do some individuals with mutations in the same gene
develop Moebius syndrome while others do not? What are the specific environmental factors that
contribute to the development of the disorder, in addition to the known effects of certain drugs such as
misoprostol and various vasoconstrictive agents? And how can we use this knowledge to develop effective
treatments for Moebius syndrome?